Risk of chemotherapy-induced febrile neutropenia in cancer patients receiving pegfilgrastim prophylaxis: does timing of administration matter?
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1433-7339
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Risk of chemotherapy-induced febrile neutropenia in cancer patients receiving pegfilgrastim prophylaxis: does timing of administration matter? ; volume:24 ; number:5 ; day:25 ; month:11 ; year:2015 ; pages:2309-2316 ; date:5.2016
Supportive care in cancer ; 24, Heft 5 (25.11.2015), 2309-2316, 5.2016
- Urheber
-
Weycker, Derek
- Beteiligte Personen und Organisationen
-
Li, Xiaoyan
Figueredo, Jacqueline
Barron, Rich
Tzivelekis, Spiros
Hagiwara, May
SpringerLink (Online service)
- DOI
-
10.1007/s00520-015-3036-7
- URN
-
urn:nbn:de:1111-2016032947061
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 08:57 UTC
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Weycker, Derek
- Li, Xiaoyan
- Figueredo, Jacqueline
- Barron, Rich
- Tzivelekis, Spiros
- Hagiwara, May
- SpringerLink (Online service)
Ähnliche Objekte (12)
Risk of chemotherapy-induced febrile neutropenia with early discontinuation of pegfilgrastim prophylaxis in US clinical practice
Bestimmung der Wärmeleitfähigkeit der Stranggiesspulver und -schlacken
Assessment of Chemotherapy-Induced Febrile Neutropenia in Cancer Patients
Cost-Effectiveness Analysis of Prophylaxis Treatment Strategies to Reduce the Incidence of Febrile Neutropenia in Patients with Early-Stage Breast Cancer or Non-Hodgkin Lymphoma
Granulocyte colony-stimulating factor (filgrastim) in chemotherapy-induced febrile neutropenia
Zhu wang de Ou zhou : 17-18 shi ji de gong ting zheng zhi yu quan li bo yi = Das Europa der Könige
Effect of POD24 on the prognosis of follicular and other indolent B-cell non-hodgkin lymphomas
Multiple organs involved in the pathogenesis of non-alcoholic fatty liver disease
Optimal $$L^2}$$ L 2 -growth of the generalized Rosenau equation
Pegfilgrastim for primary prophylaxis of febrile neutropenia in multiple myeloma
Technical evaluation of methods for identifying chemotherapy-induced febrile neutropenia in healthcare claims databases
q-Mittag-Leffler stability and Lyapunov direct method for differential systems with q-fractional order
Risk of chemotherapy-induced febrile neutropenia with early discontinuation of pegfilgrastim prophylaxis in US clinical practice
Bestimmung der Wärmeleitfähigkeit der Stranggiesspulver und -schlacken
Assessment of Chemotherapy-Induced Febrile Neutropenia in Cancer Patients
Cost-Effectiveness Analysis of Prophylaxis Treatment Strategies to Reduce the Incidence of Febrile Neutropenia in Patients with Early-Stage Breast Cancer or Non-Hodgkin Lymphoma
Granulocyte colony-stimulating factor (filgrastim) in chemotherapy-induced febrile neutropenia
Zhu wang de Ou zhou : 17-18 shi ji de gong ting zheng zhi yu quan li bo yi = Das Europa der Könige
Effect of POD24 on the prognosis of follicular and other indolent B-cell non-hodgkin lymphomas
Multiple organs involved in the pathogenesis of non-alcoholic fatty liver disease
Optimal $$L^2}$$ L 2 -growth of the generalized Rosenau equation
Pegfilgrastim for primary prophylaxis of febrile neutropenia in multiple myeloma
Technical evaluation of methods for identifying chemotherapy-induced febrile neutropenia in healthcare claims databases
q-Mittag-Leffler stability and Lyapunov direct method for differential systems with q-fractional order
Risk of chemotherapy-induced febrile neutropenia with early discontinuation of pegfilgrastim prophylaxis in US clinical practice
Bestimmung der Wärmeleitfähigkeit der Stranggiesspulver und -schlacken
Assessment of Chemotherapy-Induced Febrile Neutropenia in Cancer Patients
Cost-Effectiveness Analysis of Prophylaxis Treatment Strategies to Reduce the Incidence of Febrile Neutropenia in Patients with Early-Stage Breast Cancer or Non-Hodgkin Lymphoma
Granulocyte colony-stimulating factor (filgrastim) in chemotherapy-induced febrile neutropenia
Zhu wang de Ou zhou : 17-18 shi ji de gong ting zheng zhi yu quan li bo yi = Das Europa der Könige
Effect of POD24 on the prognosis of follicular and other indolent B-cell non-hodgkin lymphomas
Multiple organs involved in the pathogenesis of non-alcoholic fatty liver disease
Optimal $$L^2}$$ L 2 -growth of the generalized Rosenau equation
Pegfilgrastim for primary prophylaxis of febrile neutropenia in multiple myeloma
Technical evaluation of methods for identifying chemotherapy-induced febrile neutropenia in healthcare claims databases